Zhejiang CONBA Pharmaceutical Co.,Ltd. (600572.SS)
CNY 4.77
(0.0%)
CNY 4.77
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 788.26 Million CNY | -10.44% |
| 2022 | 880.17 Million CNY | -74.66% |
| 2021 | 3.47 Billion CNY | 214.08% |
| 2020 | 1.1 Billion CNY | 16.23% |
| 2019 | 951.49 Million CNY | -7.6% |
| 2018 | 1.02 Billion CNY | 13.56% |
| 2017 | 906.81 Million CNY | 90.49% |
| 2016 | 476.05 Million CNY | -15.51% |
| 2015 | 563.45 Million CNY | -29.6% |
| 2014 | 800.35 Million CNY | 66.7% |
| 2013 | 480.11 Million CNY | 28.82% |
| 2012 | 372.69 Million CNY | 11.49% |
| 2011 | 334.3 Million CNY | 85.2% |
| 2010 | 180.5 Million CNY | 72.59% |
| 2009 | 104.58 Million CNY | 139.6% |
| 2008 | 43.64 Million CNY | -64.65% |
| 2007 | 123.46 Million CNY | 180.51% |
| 2006 | 44.01 Million CNY | -9.49% |
| 2005 | 48.62 Million CNY | 68.38% |
| 2004 | 28.88 Million CNY | -37.47% |
| 2003 | 46.18 Million CNY | -16.27% |
| 2002 | 55.16 Million CNY | 18.99% |
| 2001 | 46.36 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 137.63 Million CNY | -49.08% |
| 2024 Q1 | 270.26 Million CNY | 1639.47% |
| 2024 Q3 | 170.78 Million CNY | 24.09% |
| 2023 Q3 | 152.21 Million CNY | -36.4% |
| 2023 Q4 | -17.55 Million CNY | -111.53% |
| 2023 Q1 | 414.27 Million CNY | 137.46% |
| 2023 FY | 788.26 Million CNY | -10.44% |
| 2023 Q2 | 239.33 Million CNY | -42.23% |
| 2022 Q1 | 317.08 Million CNY | -85.12% |
| 2022 FY | 880.17 Million CNY | -74.66% |
| 2022 Q2 | 163.13 Million CNY | -48.55% |
| 2022 Q3 | 235.44 Million CNY | 44.32% |
| 2022 Q4 | 174.46 Million CNY | -25.9% |
| 2021 Q1 | 99.1 Million CNY | 1241.52% |
| 2021 Q3 | 13.86 Million CNY | -94.94% |
| 2021 Q4 | 2.13 Billion CNY | 15272.9% |
| 2021 FY | 3.47 Billion CNY | 214.08% |
| 2021 Q2 | 273.78 Million CNY | 176.25% |
| 2020 Q4 | 7.38 Million CNY | -94.21% |
| 2020 FY | 1.1 Billion CNY | 16.23% |
| 2020 Q3 | 127.61 Million CNY | -65.65% |
| 2020 Q2 | 371.51 Million CNY | 33.91% |
| 2020 Q1 | 277.42 Million CNY | 137.41% |
| 2019 Q2 | 281.32 Million CNY | 15.39% |
| 2019 Q3 | 177.42 Million CNY | -36.93% |
| 2019 Q1 | 243.81 Million CNY | 107.62% |
| 2019 FY | 951.49 Million CNY | -7.6% |
| 2019 Q4 | -741.63 Million CNY | -518.0% |
| 2018 Q2 | 329.7 Million CNY | 3.95% |
| 2018 FY | 1.02 Billion CNY | 13.56% |
| 2018 Q4 | 117.43 Million CNY | -55.76% |
| 2018 Q1 | 317.16 Million CNY | 94.19% |
| 2018 Q3 | 265.43 Million CNY | -19.49% |
| 2017 FY | 906.81 Million CNY | 90.49% |
| 2017 Q4 | 163.32 Million CNY | -41.68% |
| 2017 Q3 | 280.05 Million CNY | 16.56% |
| 2017 Q2 | 240.27 Million CNY | 7.66% |
| 2017 Q1 | 223.16 Million CNY | 1586.88% |
| 2016 Q3 | 150.01 Million CNY | -8.94% |
| 2016 FY | 476.05 Million CNY | -15.51% |
| 2016 Q4 | -15 Million CNY | -110.01% |
| 2016 Q2 | 164.74 Million CNY | -6.56% |
| 2016 Q1 | 176.3 Million CNY | 185.95% |
| 2015 Q2 | 382.16 Million CNY | 101.9% |
| 2015 FY | 563.45 Million CNY | -29.6% |
| 2015 Q1 | 189.28 Million CNY | -12.71% |
| 2015 Q4 | -205.12 Million CNY | -204.06% |
| 2015 Q3 | 197.13 Million CNY | -48.42% |
| 2014 Q2 | 214.58 Million CNY | 27.63% |
| 2014 Q3 | 200.79 Million CNY | -6.43% |
| 2014 Q4 | 216.85 Million CNY | 8.0% |
| 2014 FY | 800.35 Million CNY | 66.7% |
| 2014 Q1 | 168.13 Million CNY | 36.18% |
| 2013 Q4 | 123.46 Million CNY | -6.06% |
| 2013 Q2 | 125.63 Million CNY | 26.17% |
| 2013 Q1 | 99.57 Million CNY | -37.16% |
| 2013 FY | 480.11 Million CNY | 28.82% |
| 2013 Q3 | 131.43 Million CNY | 4.61% |
| 2012 FY | 372.69 Million CNY | 11.49% |
| 2012 Q1 | 58.11 Million CNY | -3.66% |
| 2012 Q4 | 158.47 Million CNY | 154.51% |
| 2012 Q3 | 62.26 Million CNY | -33.65% |
| 2012 Q2 | 93.84 Million CNY | 61.47% |
| 2011 Q3 | 60.7 Million CNY | -0.03% |
| 2011 Q2 | 60.72 Million CNY | -50.95% |
| 2011 Q1 | 123.78 Million CNY | 117.61% |
| 2011 FY | 334.3 Million CNY | 85.2% |
| 2011 Q4 | 60.32 Million CNY | -0.62% |
| 2010 Q2 | 45.46 Million CNY | 15.68% |
| 2010 Q1 | 39.3 Million CNY | 3.84% |
| 2010 FY | 180.5 Million CNY | 72.59% |
| 2010 Q4 | 56.88 Million CNY | 46.44% |
| 2010 Q3 | 38.84 Million CNY | -14.56% |
| 2009 Q3 | 27.43 Million CNY | 36.54% |
| 2009 Q2 | 20.09 Million CNY | 4.58% |
| 2009 Q1 | 19.21 Million CNY | -37.02% |
| 2009 FY | 104.58 Million CNY | 139.6% |
| 2009 Q4 | 37.85 Million CNY | 37.99% |
| 2008 Q3 | -14.58 Million CNY | -370.89% |
| 2008 Q4 | 30.5 Million CNY | 309.08% |
| 2008 FY | 43.64 Million CNY | -64.65% |
| 2008 Q1 | 22.34 Million CNY | -59.6% |
| 2008 Q2 | 5.38 Million CNY | -75.9% |
| 2007 Q2 | 12.36 Million CNY | -24.83% |
| 2007 Q1 | 16.44 Million CNY | 21.38% |
| 2007 FY | 123.46 Million CNY | 180.51% |
| 2007 Q3 | 27.92 Million CNY | 125.86% |
| 2007 Q4 | 55.31 Million CNY | 98.1% |
| 2006 Q1 | 15.31 Million CNY | -11.99% |
| 2006 Q2 | 4.76 Million CNY | -68.87% |
| 2006 Q3 | 10.38 Million CNY | 117.85% |
| 2006 Q4 | 13.54 Million CNY | 30.48% |
| 2006 FY | 44.01 Million CNY | -9.49% |
| 2005 Q1 | 14.95 Million CNY | 301.96% |
| 2005 Q4 | 17.39 Million CNY | 119.17% |
| 2005 Q3 | 7.93 Million CNY | -4.76% |
| 2005 FY | 48.62 Million CNY | 68.38% |
| 2005 Q2 | 8.33 Million CNY | -44.28% |
| 2004 FY | 28.88 Million CNY | -37.47% |
| 2004 Q1 | 13.24 Million CNY | 20.16% |
| 2004 Q2 | 3.17 Million CNY | -76.06% |
| 2004 Q3 | 8.74 Million CNY | 175.67% |
| 2004 Q4 | 3.72 Million CNY | -57.43% |
| 2003 Q4 | 11.02 Million CNY | -37.02% |
| 2003 Q3 | 17.5 Million CNY | 0.0% |
| 2003 FY | 46.18 Million CNY | -16.27% |
| 2002 FY | 55.16 Million CNY | 18.99% |
| 2001 FY | 46.36 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.9 Billion CNY | 83.945% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.39 Billion CNY | 76.772% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 82.83 Million CNY | -851.562% |
| Aurora Optoelectronics Co.,Ltd. | -505.31 Million CNY | 255.996% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -37.56 Million CNY | 2198.157% |
| NanJing Pharmaceutical Company Limited | 1.49 Billion CNY | 47.173% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 114.81 Million CNY | -586.567% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 42.255% |